Perhaps ask big pharma the same question as none of them seem to want to license our DEP drugs to date ?
These results are good because they have been achieved on top of the SOC but let's not forget it is only one CR .... maybe if there were 8-10 CR's I would be little more excited ?
Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-7
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $45.99M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.5¢ | $114.6K | 998.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171158 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 204 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |